sameAs
The effect of urocanic acid on graft rejection in an experimental model of orthotopic corneal transplantation in rabbits.Modulation of the early inflammatory microenvironment in the alkali-burned eye by systemically administered interferon-γ-treated mesenchymal stromal cellsPrevention of corneal allograft rejection in a mouse model of high risk recipientsA Comparative Study of the Therapeutic Potential of Mesenchymal Stem Cells and Limbal Epithelial Stem Cells for Ocular Surface Reconstruction.The Favorable Effect of Mesenchymal Stem Cell Treatment on the Antioxidant Protective Mechanism in the Corneal Epithelium and Renewal of Corneal Optical Properties Changed after Alkali BurnsApplication of Concanavalin A during immune responsiveness skin-swelling tests facilitates measurement interpretation in mammalian ecology.Molecular Hydrogen Effectively Heals Alkali-Injured Cornea via Suppression of Oxidative Stress.Separation of multiple genes controlling the T-cell proliferative response to IL-2 and anti-CD3 using recombinant congenic strains.Interleukin-1 and interferon-alpha augment interleukin-2 (IL-2) production by distinct mechanisms at the IL-2 mRNA level.Effects of direct current on T cell activity: modulation of interleukin-2 production.Evaluation of corneal graft rejection in a mouse modelControlled gentamicin release from multi-layered electrospun nanofibrous structures of various thicknesses.A rapid separation of two distinct populations of mouse corneal epithelial cells with limbal stem cell characteristics by centrifugation on percoll gradient.Treatment of ocular surface injuries by limbal and mesenchymal stem cells growing on nanofiber scaffolds.Distinct regulatory roles of transforming growth factor-beta and interleukin-4 in the development and maintenance of natural and induced CD4+ CD25+ Foxp3+ regulatory T cells.Alloantigen-induced, T-cell-dependent production of nitric oxide by macrophages infiltrating skin allografts in mice.Reverse effect of indomethacin on the immunosuppressive activity of boar seminal immunosuppressive fraction.Nitric oxide as a regulatory and effector molecule in the immune system.Augmented production of proinflammatory cytokines and accelerated allotransplantation reactions in heroin-treated mice.Antigen recognition and IL-2 receptor gene expression as evidence against clonal deletion in mice with neonatally induced transplantation tolerance.Effects of boar seminal immunosuppressive fraction on production of cytokines by Concanavalin A-stimulated spleen cells and on proliferation of B lymphoma cell lines.The effect of cocaine sensitization on mouse immunoreactivity.Effects of lipopolysaccharide and chlorpromazine on glucocorticoid receptor-mediated gene transcription and immunoreactivity: a possible involvement of p38-MAP kinase.A new animal model of (chronic) depression induced by repeated and intermittent lipopolysaccharide administration for 4 months.Perspectives of Stem Cell-Based Therapy for Age-Related Retinal Degenerative Diseases.Targeted neural differentiation of murine mesenchymal stem cells by a protocol simulating the inflammatory site of neural injury.Transplantation immunity in the brain.Distinct Immunoregulatory Mechanisms in Mesenchymal Stem Cells: Role of the Cytokine Environment.Comparison of the sensitivity of in vivo detection of immunological tolerance in the xenogeneic system.Effect of desipramine on immunological parameters in mice, and their reversal by stress.Cellular and humoral immune responses to chimeric EGFP-pseudocapsids derived from the mouse polyomavirus after their intranasal administration.Mesenchymal Stem Cells Attenuate the Adverse Effects of Immunosuppressive Drugs on Distinct T Cell Subopulations.Polyomavirus EGFP-pseudocapsids: analysis of model particles for introduction of proteins and peptides into mammalian cells.The Identification of Interferon-γ as a Key Supportive Factor for Retinal Differentiation of Murine Mesenchymal Stem Cells.Transfer of mesenchymal stem cells and cyclosporine A on alkali-injured rabbit cornea using nanofiber scaffolds strongly reduces corneal neovascularization and scar formation.Suppression of IL-10 production by activated B cells via a cell contact-dependent cyclooxygenase-2 pathway upregulated in IFN-γ-treated mesenchymal stem cells.Treatment of alkali-injured cornea by cyclosporine A-loaded electrospun nanofibers - An alternative mode of therapy.The Supportive Role of Insulin-Like Growth Factor-I in the Differentiation of Murine Mesenchymal Stem Cells into Corneal-Like Cells.Characterization of human adipose tissue-derived stromal cells isolated from diabetic patient's distal limbs with critical ischemia.Relative immunogenicity and tolerogenicity of individual regions or segments of the MHC.
P50
Q32128212-0E02941C-2C04-4DB2-AF2B-AF2118AA1696Q34291269-D060E786-D640-487F-A17A-2D233CA0B680Q35592457-685EFCE5-FD08-4308-8D29-4AFE18F65C90Q35975412-BE70431E-3F9A-4E9D-ACFE-77611C1C38F3Q36530413-F3B135E5-A180-4979-A4F6-40A74C88505BQ37060474-D7FF33F9-74CB-49E3-AA5A-C416A1131EC0Q37733585-0AF7DEC1-D408-4BBA-B86B-8B6B421DC9D1Q41005255-9054D335-DE0C-4BCE-B8B3-3D3A11AEA7F6Q41443917-BBBFE451-9F2D-4E51-BE20-5721D3527D8DQ41464765-E3C50F46-5B87-4C15-A3BF-0CBC21B51535Q41813812-7DDF5EA6-F903-46F9-838D-934B724DF9A4Q41899722-5BDDDD7D-D6F0-446F-B61B-A8691163D0EEQ42813271-2D17BB27-FEC1-4579-8609-75E6D51A1254Q43007568-E3C243FE-72A6-4528-9759-F45354618E3AQ43279102-12FD58D5-C10E-49E3-B4F5-5B8ECD3E2E62Q43949046-FD3C9CC0-B382-4F79-BC6F-C7F666A08601Q43978597-523E0588-0573-4DF9-A396-F6698FBD7540Q43992335-5B1C09D3-9A42-4F14-AE6F-ED396A79D4F6Q44373646-1AFE2FE3-C130-411C-9B95-97B47FA05512Q44416012-9B9E30EF-AA5B-4BEE-BAFA-D58AECBFBF85Q44507675-6AE4CDB5-A5E6-4203-BBCC-250A838DBE82Q44732302-09431951-D82C-43F8-A74C-1E2668956003Q45181182-0634C583-DED6-4BE6-BFC4-DBC4570FDEADQ45799497-5E7E8201-6640-4291-A41B-22B6E17D3AB4Q47094343-C0C46468-BAEB-43B3-A9FD-11B4975D0552Q48105363-F3D75B72-649A-49C7-A64A-15AD7D08C560Q48330286-8C492B88-712F-45E2-9AC0-097DAC1618A2Q48336724-BB171B0C-459A-4C2B-8E74-18BA6E67D1CDQ48949906-C105475F-9F9D-4292-BBA0-42B3B9BA2150Q50522230-0F25724A-8E70-46EA-ADB8-14BB82DEBF7FQ50635555-3C72E485-7160-4F81-A2F3-814F7798D7DEQ50733062-DE4E1CF5-9B1E-4275-B69C-5CBB9D393CC3Q50747442-E3816FBF-3091-45EF-89A5-4FA924BCA1D0Q50879668-8451315E-4596-480A-8CE5-6DC33EC9E55FQ51550661-057E952A-FD68-420C-AE9A-679F62719BAEQ51703801-FE196A46-DA4F-4E3F-A76C-90AEAD3C6B38Q53099082-77E463F9-C0E4-477A-A07C-49EE47B7A89DQ53128762-C7257D9D-AABF-4B11-BE3A-6D10A5166237Q54521735-ED9D36D7-C847-447D-A753-D776E3650132Q54528136-7D422F3C-1740-42B2-85C3-A6FD4C79CE8F
P50
description
badatel v oblasti transplantační imunologie
@cs
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Vladimír Holáň
@ast
Vladimír Holáň
@cs
Vladimír Holáň
@en
Vladimír Holáň
@es
Vladimír Holáň
@nl
type
label
Vladimír Holáň
@ast
Vladimír Holáň
@cs
Vladimír Holáň
@en
Vladimír Holáň
@es
Vladimír Holáň
@nl
altLabel
Vladimir Holan
@ast
Vladimir Holan
@en
Vladimir Holan
@es
Vladimir Holan
@nl
prefLabel
Vladimír Holáň
@ast
Vladimír Holáň
@cs
Vladimír Holáň
@en
Vladimír Holáň
@es
Vladimír Holáň
@nl
P214
P244
P106
P1153
7102162412
P19
P21
P213
0000 0000 5581 6243
P214
P244
P31
P496
0000-0002-2011-3390
P569
1950-05-18T00:00:00Z
1950-11-13T00:00:00Z
P691
nlk20050169384
P735
P7859
lccn-n88112674